Hiperemezis Gravidarumda Metoklopramid Kullanımına Bağlı Gelişen Distoni: Olgu Sunumu

Abstract

Metoklopramid, hiperemezis gravidarumda sık kullanılan dopamin reseptör antagonisti olan anti-emetik bir ilaçtır. Akut distoni, metoklopramid tedavisinin 1-3. günlerinde, özellikle çocuklarda ve genç erişkinlerde ortaya çıkan nadir bir yan etkidir. Bu makalede hiperemezis gravidarum nedeniyle metoklopramid kullanan ve buna bağlı distoni gelişen bir olgu sunulmuş olup hiperemezis gravidarum olgularında distoni gelişmesi durumunda bu tablonun metoklopramidin yan etkisi olabileceği hatırlanmalıdır

Keywords

• Distoni, Metoklopramid, Hiperemezis Gravidarum

-

Abstract

Metoclopramide is an anti-emetic drug used frequently in hyperemesis gravidarum with dopamine receptor antagonistic properties. Acute dystonia is a rare side effect of metoclopramide encountered especially in children and young adults at first 3 days of treatment. In this case report, dystonia developed after metoclopramide treatment in a woman with hyperemesis gravidarum is presented and it is emphasized that in women with hyperemesis gravidarum, dystonia might be regarded as a side effect of metoclopramide

Keywords

• -

References

1. Kallen B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol 1987;26(4):291-302.
2. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989;149(11):2486-92.
3. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide: An updated review of its pharmacological properties and clinical use. Drugs 1983;25(5):451-94.
4. Cinqetti M, Bonetti P, Bertamini P. Current role of antidopaminergic drugs in pediatrics. Pediatr Med Chir 2000;22(1):1-7.
5. Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) 1985;291(6500):930-2.
6. Söğüt Ö, Kaya H, Solduk L, ve ark. Metoklopramid kullanımına bağlı gelişen akut distoni: iki olgu sunumu. Akademik Acil Tıp Olgu Sunumları Dergisi 2011;2(1):50-3.
7. Jackisch R, Kruchen A, Sauermann W, et al. The antiparkinsonian drugs budipine and biperiden are use- dependent (uncompetitive) NMDA receptor antagonists. Eur J Pharmacol 1994;264(2):207-11.
8. Grimes JD, Hassan MN, Preston DN. Adverse neurologic effects of metoclopramide. Can Med Assoc J 1982;126(1):23-5.

9. Hagen EM, Farbu E, Bindoff L. Acute dystonia caused by metoclopramide (Afipran) therapy. Tidsskr Nor Laegeforen 2001;121(18):2162-3.
10. Uluğ NC, Uluğ M. Metoklopramid Kullanımına Bağlı Gelişen Akut Distoni Olgusu. Klinik Psikofarmakoloji Bülteni 2011;21:70-2.
11. Cezard C, Nisse P, Quaranta S, et al. Acute dystonia from metoclopramide in children. Therapie 2003;58(4):367-70.
12. Guala A, Mittino D, Ghini T, et al. Are metoclopramide dystonias familial? Pediatr Med Chir 1992;14(6):617-8.
13. Van Der Padt A, van Schaik RH, Sonneveld P. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. Neth J Med 2006;64(5):160-162.
14. Balamtekin N, Doksal A, Gülgün M, ve ark. Olgu sunumu: Metoklopramide bağlı gelişenakut distoni. Gülhane Tıp Dergisi 2006;48(3):187-8.